[ET Net News Agency, 25 August 2025] Citi raised the target price for CSPC Pharma 
(01093) to HKD12.1 from HKD9.2 and maintained the "buy" rating. 
  The research house said it cuts 25E/26E/27E revenue forecasts by 13%/11%/9% to factor in
the sales trend, and EPS forecasts by 10%/3%/1% on higher BD revenue and lower selling  
expense. (rc) 



 
 